US 7998992
Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
granted A61KA61K31/421A61K31/422
Quick answer
US patent 7998992 (Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1) held by Institute of Medicinal Molecular Design, Inc. expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Institute of Medicinal Molecular Design, Inc.
- Grant date
- Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/421, A61K31/422, A61K31/4412, A61K31/4439